Bloating, nausea, and abdominal pain are symptoms that both IBS and gastroparesis produce. The difference is where the problem originates and whether it can be measured. IBS is diagnosed by symptom criteria and is primarily considered a lower GI disorder. Gastroparesis is delayed stomach emptying that can be confirmed with an objective test. When gastroparesis is the actual problem, IBS treatments directed at the colon will not resolve symptoms caused by a stomach that is not moving food forward. Recognizing whether your symptoms point to your upper or lower GI tract, and whether they include hallmarks of delayed gastric emptying, is the first step toward getting the right evaluation.
What is gastroparesis?
Gastroparesis is a motility disorder in which the stomach empties its contents into the small intestine more slowly than normal, without any physical blockage causing the delay. In a healthy stomach, coordinated contractions controlled by the vagus nerve and the interstitial cells of Cajal (ICC, the pacemaker cells of the gut) move food from the stomach into the duodenum within 4 hours. In gastroparesis, this process is impaired. The result is food sitting in the stomach for extended periods, causing nausea, vomiting, early satiety, postprandial fullness, upper abdominal pain, and bloating.
The diagnostic standard for gastroparesis is gastric emptying scintigraphy (GES). The patient eats a standardized meal (typically egg whites with toast and jam, labeled with a radioactive tracer, technetium-99m sulfur colloid) and imaging is performed at 0, 1, 2, and 4 hours. Retention of more than 10% of the meal at 4 hours confirms delayed gastric emptying. The severity is graded: mild (11-20% retention at 4 hours), moderate (21-35%), and severe (more than 35%). Studies shorter than 4 hours miss approximately 30% of gastroparesis cases, according to Abell and colleagues.
What causes gastroparesis?
Gastroparesis has three major categories of cause, each accounting for roughly one-third of cases in large epidemiologic studies.
- Diabetic gastroparesis. Long-standing diabetes (both type 1 and type 2) can cause autonomic neuropathy that damages the vagus nerve and impairs gastric motility. Approximately 20-50% of patients with long-standing diabetes develop some degree of delayed gastric emptying, though not all are symptomatic (Bharucha et al. 2015).
- Post-surgical gastroparesis. Surgeries involving the stomach, vagus nerve, or upper GI tract (fundoplication, bariatric procedures, vagotomy) can directly damage the nerves and muscles controlling gastric emptying.
- Idiopathic gastroparesis. In roughly one-third of cases, no identifiable cause is found. Some idiopathic cases may follow viral infections (post-viral gastroparesis), but the viral connection is often difficult to confirm. This group has the most symptom overlap with functional dyspepsia and IBS.
Less common causes include medications (opioids, anticholinergics, GLP-1 receptor agonists), connective tissue disorders (scleroderma, Ehlers-Danlos syndrome), hypothyroidism, Parkinson's disease, and amyloidosis. Any condition or medication that impairs gastric motility can produce gastroparesis.
How do IBS and gastroparesis symptoms overlap?
The overlap is significant, which is why misdiagnosis occurs. Both conditions produce bloating, abdominal pain, nausea, and altered bowel habits. A clinician who does not specifically evaluate gastric motility cannot distinguish them from symptoms alone.
| Symptom | IBS | Gastroparesis |
|---|---|---|
| Bloating | Very common, often diffuse | Very common, often upper abdominal |
| Abdominal pain | Core criterion (Rome IV), variable location | Common, typically epigastric |
| Nausea | Occasional | Prominent, often the dominant complaint |
| Vomiting | Uncommon | Common, may contain undigested food hours after eating |
| Early satiety | Not typical | Very common, defining feature |
| Postprandial fullness | Possible | Prominent, feeling of food sitting in stomach |
| Diarrhea | IBS-D subtype | Less common, unless SIBO is present |
| Constipation | IBS-C subtype | Possible due to global dysmotility |
| Weight loss | Not typical | Common in moderate-severe cases |
What are the key differentiators?
Several clinical features help distinguish gastroparesis from IBS, even before diagnostic testing is performed.
- Upper vs lower GI symptom predominance. Gastroparesis symptoms center in the upper abdomen (epigastric region). The dominant complaints are nausea, early satiety, vomiting, and a sensation that food is not leaving the stomach. IBS symptoms tend to center in the lower abdomen and are more closely related to defecation patterns. If your main complaints are above the navel rather than below it, gastroparesis should be considered.
- Early satiety. Feeling full after just a few bites of food is characteristic of gastroparesis and is not a typical IBS feature. In gastroparesis, the stomach has not emptied from the previous meal, so there is less room for new food. This symptom is one of the most distinguishing features.
- Nausea as the dominant symptom. While IBS patients may experience occasional nausea, it is rarely the primary complaint. In gastroparesis, nausea is often the most bothersome symptom and can be constant or triggered predictably by eating, especially solid foods.
- Vomiting of undigested food. Vomiting food that was eaten hours earlier (sometimes 6-12 hours) is highly suggestive of gastroparesis. This does not occur in IBS. The undigested nature of the vomited material indicates food has been retained in the stomach rather than progressing through the GI tract.
- Relationship to meal composition. Gastroparesis symptoms are typically worse with solid foods, high-fat meals, and high-fiber foods because these take longer to empty from the stomach. Liquids may be tolerated better because liquid emptying is often preserved even when solid emptying is impaired. IBS symptoms are more variably related to food composition.
The gastroparesis-SIBO overlap
Gastroparesis and SIBO frequently coexist, creating a diagnostic challenge. Delayed gastric emptying impairs the normal clearance mechanisms that keep bacterial populations low in the small intestine. The migrating motor complex, which sweeps bacteria and debris from the small intestine between meals, depends on coordinated motility from the stomach through the small bowel. When gastric motility is impaired, the downstream effects can promote bacterial overgrowth. George and colleagues (2012) documented significantly higher rates of SIBO in gastroparesis patients compared to controls.
This overlap means that a patient with gastroparesis may develop secondary SIBO that produces lower GI symptoms (diarrhea, gas, lower abdominal bloating) on top of the upper GI symptoms from delayed emptying. The lower GI symptoms may be attributed to IBS, masking the gastroparesis that is driving the entire picture. Conversely, treating SIBO alone without addressing the gastroparesis will result in recurrence because the motility problem that allowed bacterial overgrowth has not been corrected.
How are IBS and gastroparesis diagnosed differently?
IBS is diagnosed clinically using the Rome IV criteria, which are symptom-based and do not require any motility testing. Gastroparesis requires objective evidence of delayed gastric emptying through a 4-hour gastric emptying scintigraphy. An upper endoscopy is also typically performed to rule out mechanical obstruction before the diagnosis is made. The gastric emptying study is not part of the standard IBS workup, which is why gastroparesis gets missed in patients labeled with IBS.
| Feature | IBS | Gastroparesis |
|---|---|---|
| Diagnostic method | Symptom criteria (Rome IV) | 4-hour gastric emptying scintigraphy |
| Confirmatory test | None | Yes (GES or SmartPill) |
| Symptom location | Primarily lower GI | Primarily upper GI |
| Underlying cause | Unknown (diagnosis of exclusion) | Identifiable in ~2/3 of cases |
| Standard workup includes motility testing? | No | N/A (motility testing is the diagnosis) |
How do treatment approaches differ?
IBS treatment focuses on managing bowel habits and pain through dietary modification (low-FODMAP), antispasmodics, fiber supplementation, and gut-brain modulators. These interventions target the lower GI tract and visceral pain processing. Gastroparesis treatment targets gastric motility and symptom relief through a different set of interventions. Dietary modification for gastroparesis involves low-fat, low-fiber meals in small, frequent portions, which is often the opposite of IBS dietary advice that may emphasize fiber. Prokinetic medications (metoclopramide, domperidone, erythromycin at low doses) are used to accelerate gastric emptying. Antiemetics address nausea and vomiting. In severe cases, pyloric interventions (gastric per-oral endoscopic myotomy, or G-POEM) or gastric electrical stimulation may be considered.
The dietary divergence is clinically important. A patient with gastroparesis who is placed on a high-fiber IBS diet may worsen because fiber slows gastric emptying further. Recognizing whether the problem is in the stomach or the colon determines which dietary strategy will help and which will hurt.
⚠️If nausea, early satiety, and upper abdominal fullness are your primary symptoms, tell your gastroenterologist specifically. These symptoms should prompt consideration of a gastric emptying study rather than an IBS diagnosis based on Rome IV criteria alone.
Frequently Asked Questions
Can you have both IBS and gastroparesis?
Yes. Gastroparesis and IBS can coexist, and gastroparesis can cause secondary changes (like SIBO) that produce IBS-type lower GI symptoms. Some patients have both impaired gastric emptying and lower GI motility or sensitivity issues. Treating the gastroparesis component may resolve some but not all IBS symptoms.
Is gastroparesis more common in women?
Yes. Gastroparesis is approximately 4 times more common in women than men, particularly idiopathic gastroparesis. The reasons are not fully understood but may involve hormonal influences on gastric motility. IBS is also more common in women. This demographic overlap may contribute to gastroparesis being labeled as IBS in female patients.
Can IBS medications make gastroparesis worse?
Some can. Opioid-based pain medications slow gastric motility. Anticholinergic antispasmodics (hyoscyamine, dicyclomine) can reduce gastric contractions. Fiber supplements may worsen gastroparesis symptoms because fiber slows gastric emptying. If you have undiagnosed gastroparesis, these standard IBS treatments may explain why your symptoms are not improving or are getting worse.
What does early satiety feel like?
Early satiety feels like being uncomfortably full after eating a very small amount of food, sometimes just a few bites. It is different from normal fullness because it occurs disproportionately early in a meal. Patients often describe it as feeling like their stomach is not emptying from the previous meal, which in gastroparesis is literally what is happening.
Does gastroparesis go away?
Post-viral gastroparesis may resolve over months to years. Diabetic gastroparesis is typically chronic but can be managed with dietary changes, prokinetics, and glucose control. Idiopathic gastroparesis varies; some patients improve spontaneously while others require long-term management. Gastroparesis is generally considered a chronic condition, but symptom severity can fluctuate.
⚠️This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.